Targeted Strategies for Today's Evolving Markets

MissionIR Blog

DARA BioSciences (DARA) Presents at Rodman & Renshaw Conference

DARA BioSciences, Inc. (NASDAQ: DARA) is an oncology supportive care pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatments. DARA holds the exclusive U.S. marketing rights to Soltamox, a novel oral liquid formulation of tamoxifen citrate (the only FDA-approved version of it in the U.S.), which is widely used in the treatment and prevention of breast cancer. For more information, visit the company’s website at

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.